Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 1, 2014, Pages 299-304

  Khunluck, Tueanjai ^a   Kukongviriyapan, Veerapol ^a   Puapairoj, Anucha ^a   Khuntikeo, Narong ^a   Senggunprai, Laddawan ^a   Zeekpudsa, Ponsilp ^a   Prawan, Auemduan ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cholangiocarcinoma; NRF2; Polymorphism; Prognosis; Thai population

Indexed keywords

NFE2L2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR NRF2; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; INTRAHEPATIC BILE DUCT; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; THAILAND;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASE-CONTROL STUDIES; CHOLANGIOCARCINOMA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NF-E2-RELATED FACTOR 2; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; THAILAND; TUMOR MARKERS, BIOLOGICAL;

EID: 84894065605     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.1.299     Document Type: Article

References (28)

1. Bouligand J, Cabaret O, Canonico M, et al (2011). Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women. Clin Pharmacol Ther, 89, 60-4.
2. Buranrat B, Chau-In S, Prawan A, et al (2012). NQO1 expression correlates with cholangiocarcinoma prognosis. Asian Pac J Cancer Prev, 13, 131-6.
3. Cardinale V, Semeraro R, Torrice A, et al (2010). Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J Gastrointest Oncol, 2, 407-16.
4. Cordova EJ, Velazquez-Cruz R, Centeno F, et al (2010). The NRF2 gene variant,-653G/A, is associated with nephritis in childhood-onset systemic lupus erythematosus. Lupus, 19, 1237-42.
5. Guglielmi A, Ruzzenente A, Campagnaro T, et al (2009). Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg, 33, 1247-54.
6. Hartikainen JM, Tengstrom M, Kosma VM, et al (2012). Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer. Cancer Res, 72, 5537-46.
7. Hong CC, Ambrosone CB, Ahn J, et al (2007). Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev, 16, 1784-94.
8. Honjo S, Srivatanakul P, Sriplung H, et al (2005). Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer, 117, 854-60.
9. Khan SA, Toledano MB, Taylor-Robinson SD (2008). Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB, 10, 77-82.
10. Kukongviriyapan V (2012). Genetic polymorphism of drug metabolizing enzymes in association with risk of bile duct cancer. Asian Pac J Cancer Prev, 13, 7-15.
11. Ma X, Zhang J, Liu S, et al (2012). Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer. Cancer Chemother Pharmacol, 69, 485-94.
12. Manandhar S, Choi BH, Jung KA, et al (2012). NRF2 inhibition represses ErbB2 signaling in ovarian carcinoma cells: implications for tumor growth retardation and docetaxel sensitivity. Free Radic Biol Med, 52, 1773-85.
13. Marczak ED, Marzec J, Zeldin DC, et al (2012). Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans. Pharmacogenet Genomics, 22, 620-8.
14. Marzec JM, Christie JD, Reddy SP, et al (2007). Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J, 21, 2237-46.
15. Masuko H, Sakamoto T, Kaneko Y, et al (2011). An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV1: a longitudinal retrospective cohort study. BMC Med Genet, 12, 97.
16. Ohshima H, Bandaletova TY, Brouet I, et al (1994). Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini). Carcinogenesis, 15, 271-5.
17. Okano Y, Nezu U, Enokida Y, et al (2013). SNP (-617C>A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for Prognosis of Lung Adenocarcinoma in Japanese Non-Smoking Women. PLoS One, 8, 73794.
18. Prawan A, Kukongviriyapan V, Tassaneeyakul W, et al (2005). Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma. Eur J Cancer Prev, 14, 245-50.
19. Ren D, Villeneuve NF, Jiang T, et al (2011). Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci USA, 108, 1433-8.
20. Rushmore TH, Morton MRPickett CB (1991). The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem, 266, 11632-9.
21. Siedlinski M, Postma DS, Boer JM, et al (2009). Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population. Respir Res, 10, 73.
22. Singal AK, Vauthey JN, Grady JJStroehlein JR (2011). Intra-hepatic cholangiocarcinoma-frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center. J Cancer Res Clin Oncol, 137, 1071-8.
23. Srivatanakul P, Ohshima H, Khlat M, et al (1991). Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int J Cancer, 48, 821-5.
24. Subimerb C, Pinlaor S, Khuntikeo N, et al (2010). Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma. Mol Med Rep, 3, 597-605.
25. Taguchi K, Motohashi HYamamoto M (2011). Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells, 16, 123-40.
26. Venugopal RJaiswal AK (1996). Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci USA, 93, 14960-5.
27. von Otter M, Landgren S, Nilsson S, et al (2010). Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease. BMC Med Genet, 11, 36.
28. Wirasorn K, Ngamprasertchai T, Chindaprasirt J, et al (2013). Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol, 5, 81-7.